全面了解 香港首個AI病毒檢測系統
香港生物科技協會主席、AI病毒檢測系統總指揮于常海教授及首席科學家曾瑞英博士出席(RTHK) 香港電台節目「防疫速遞」 (繼續閱讀…)
Read More
網誌
生物科技協會研發快測定量系統 ART-Quant， 上載陽性結果相片即可查病毒量，供香港人免費使用
第五波疫情致近月醫療系統負荷大，「中招」者居家抗疫或感徬徨無助，香港生物科技協會主席于常海與團隊日前研發出「ART-Quant」快測定量系統，讓檢出陽性患者，透過抗原快速測試試劑棒上T線標記的顏色深淺，知曉自身病毒載量相對值判斷嚴重程度。于常海指，患者每天透過系統追蹤，可知悉自己疫情若「差唔多到頂」，或有感冒、發燒徵狀，可準備食藥；相反，若病毒量見回落，心理上得到舒解，更可能令病情好得更快。 (繼續閱讀…)
Read More
AI依快速測試T線深淺判斷病毒量 生物科技協會設20萬次免費使用
針對快速檢測結果現時只有一條線及兩條線之分，香港生物科技協會主席于常海與團隊研發出一個名為「ART-Quant 抗原快速檢測定量系統」，只需上傳快測結果圖片，AI智能化系統就會對樣本進行自動數據分析，不出20秒即能計算出病毒載量的相對數值，得出「染疫等級」，提示患者是處於「嚴重」、「頗高」還是「偏低」帶病毒階段。 (繼續閱讀…)
Read More
关爱抑郁症，《兹心》就是 慈。
《兹心》正片于3月20日在海内外平台同步上线，敬请点击上图观赏。 抑郁症 正在折磨全球3.5億人的病症， 不分國界、不分種群、 不分年齡、不分身份、 這不是一個人的痛苦， 也不是一個人的努力， 是影響無數家庭、牽動萬千生命、 關係人類未來的社會責任， 文明發展伴隨本能的壓抑， 生之意義需要愛點燃昇華。 (繼續閱讀…)
Read More
香港生物科技協會榮譽推薦《兹心》，一部“關愛抑鬱症”紀錄大片
香港生物科技協會榮譽推薦《兹心》，它是一部“關愛抑鬱症”紀錄大片，製作嚴謹，攝影一流，科普公益，有愛有溫度，全方位角度探討，值得一看。2022年3月20日國際幸福日上午11點30分，《兹心》將似一份愛之禮在幸福中應運而“生”。期待有你見證、參與、成長、分享的足跡，也希望你收下《兹心》的祝福和希冀——願兹心幸福，被愛安頓！抑鬱症將會是後COVID-19（long COVID)其中最大的一個後遺症，大家請關注。 BIOHK 全力支持是次公益活動，本會主席于常海教授更積極參與，作為紀錄片的榮譽顧問，他希望更多人可以關注抑鬱症人士，相信世界充滿愛, 請給他們一點祝福。兹心幸福🌹, 被愛安頓 ❤️ (繼續閱讀…)
Read More
生物科技專家對市面快速測試劑功效比較
專家驗24款快測包 政府派品牌4款上榜 目前香港疫情嚴峻，而政府已經承認市民自己使用快速測試劑的結果。但是，市面上的測試劑種類繁多，價格和功效差異大，市民難以比較和選擇。為此，香港生物科技協會、香港生物醫藥創新協會聯同多位專家，对市面上的二十多種測試劑進行了科學、客觀的測評，按照其「靈敏度、特異性、穩定性」等指標，列出性能較好的測試劑，供市民參考。 (繼續閱讀…)
Read More
人物傳奇 香港生物科技協會主席于常海
于常海教授較早前東周刊訪問 為推動香港科研邁向國際創科中心願景，政府斥資過百億元於科學園成立兩個創新香港研發平台，分別聚焦生物醫療、人工智能及機械人科技。 作為生物科技學家及香港生物科技協會〔HKBIO〕主席于常海教授，除了硏發生物技術外，也是科技創新界選委。于教授積極參與推動香港創科工作，現正籌辦首個香港國際生物科技展〔BIOHK〕，將邀請各地頂尖科學家、初創企業及投資者來臨「比拚」。儘管，籌辦展會困難重重，于教授期盼盡快「疫」過天晴，並提及:「香港具有優秀生物科研研發的成果，只是欠缺宣傳，藉著這個香港國際生物科技展〔BIOHK〕，向全世界展示香港生物科技有重大成就的好機會。」 (繼續閱讀…)
Read More
香港中醫藥業正待強化發展
中央近日派出高規格宣講團來港說明十四五規劃詳情，好讓港人抓緊機遇，融入國家發展大局。就《粵港澳大灣區中醫藥高地建設方案(2020-2025)》，內地提出政策惠及港人港商，本港業界期待更多有效措施陸續推出。 在人才北上大灣區方面，國務院港澳辦副主任黃柳權表示，鼓勵香港中醫師到灣區內地城市公立醫療機構執業。截至去年底，本港共有10422名中醫師。近年不少本港學生回內地修讀中醫藥本科學位課程，現時已出現中醫師人手過多狀況。據港府推算，未來十年中醫師供應過剩數目約1600人。廣東省政府於上月底公布，香港青年具備中醫專業或相關學歷資格，可到大灣區發展所長，這尤對在內地攻讀中醫的港人畢業生提供了嶄新機會。 (繼續閱讀…)
Read More
Economic Freedom of the World 2021
2021 Annual Report is the world's premier measurement of economic freedom, ranking countries based on five areas—size of government, legal structure and property rights, access to sound money, freedom to trade internationally, regulation of credit, labour and business. In this year's report, which compares 165 countries and territories, Hong Kong…
Read More
Taiwanese biotech firms optimize R&D processes with innovative technology
In an era when consumers are demanding more from producers for better, faster, and stronger products, the biotechnology industry is not exempt. Situated in Taiwan are two companies, VIRTUALMAN and Hughes Biotechnology, paying close attention to this shift in the trend and revolutionizing R&D processes. VIRTUALMAN accelerates drug development and enhances safety In 2020,…
Read More
Biotech, digitization and indoor farming help fuel the future of agtech
The story of agtech in 2020 was one of struggles due to COVID-19 and success in spite of it, ending with a triumphant Q4: Global VC deal value in agtech totaled $2.3 billion, up 82% over Q3 and 56% over Q4 2019. So what's next? As the world begins to…
Read More
习近平：加快解决一批药品、医疗器械、医用设备、疫苗等领域“卡脖子”问题
习近平3月6日下午看望了参加全国政协十三届四次会议的医药卫生界、教育界委员，并参加联组会，听取意见和建议。习近平强调，要集中力量开展关键核心技术攻关，加快解决一批药品、医疗器械、医用设备、疫苗等领域“卡脖子”问题。要继续加大医保改革力度，常态化制度化开展药品集中带量采购，健全重特大疾病医疗保险和救助制度，深化医保基金监管制度改革，守好人民群众的“保命钱”“救命钱”。 (繼續閱讀…)
Read More
【醫療科技】香港科技園獲注資3.5億 聚焦生物科技初創
新冠肺炎疫情爆發，全球的醫療系統面臨重大挑戰，醫護人員工作量及壓力倍增。面對新趨勢所帶來的醫療衝擊，除了醫療技術不斷進步外，各項新興科技的發展也逐步協助解決現有的醫療問題。日前再獲港府注資3.5億元的香港科技園公司透露，將會投放更多資源予研發生物科技的初創企業。 (繼續閱讀…)
Read More
创新驱动，控放并举，推动生物科技产业发展
体外诊断试剂行业是生物科技产业中的新兴产业，体外诊断行业属于医疗器械板块子行业，包括体外诊断仪器和配套的诊断试剂。体外诊断试剂行业服务于实验诊断。实验诊断是临床治疗模式的第一步，也是最重要的一步，精准医疗来自精准诊断，所以快速准确的诊断是医疗的关键。 (繼續閱讀…)
Read More
Right Mix Of Government Support, Finance And Talent Make Hong Kong A Major Biotech Hub
Faced with the greatest global healthcare crisis in a century, the biotech industry has flourished during the pandemic, as demand for Covid-19 test kits, antiviral drugs and vaccines has skyrocketed. Because of its unique advantages, Hong Kong is ideally placed to capitalize on the boom in this sector. Hong Kong…
Read More
麻省理工科技评论发布2021全球十大科技突破：mRNA疫苗入选
2021年2月24日，麻省理工科技评论评选的“全球十大突破性技术”在杭州未来科技城正式发布。 入选的十大突破性技术包括：mRNA 疫苗、GPT-3、数据信托、锂金属电池、数字接触追踪、超高精度定位、远程技术、多技能 AI、TikTok 推荐算法、绿色氢能。 (繼續閱讀…)
Read More
Future Founders Initiative aims to increase female entrepreneurship in biotech
MIT faculty collaborate with members of the Boston-area biotech community to commercialize women’s discoveries and promote female entrepreneurship. The gender disparity in biotech really got Sangeeta Bhatia’s attention while she was on sabbatical. Bhatia had taken a year to focus on her startup biotech company, Glympse Bio. The startup, inspired by…
Read More
Biotech Boom
There are few circumstances that better illustrate the importance of biomedical innovation than what’s happening in society right now. Across the country and around the world, the potential for new ideas, new medicines, and new therapeutic options to, quite literally, change lives has perhaps never been more apparent. Biotech breakthroughs…
Read More
Bharat Biotech to have phase 3 efficacy data for Covaxin in 2 weeks
Krishna Ella, chairman and managing director of Bharat Biotech, said the company would come out with the phase 3 efficacy data for Covaxin in two weeks. Speaking at a webinar, Ella said that had the company combined phase 2 and 3 studies, the efficacy data could have been available sooner.…
Read More
The reckoning begins for biotech-focused Spacs
The clock is ticking for the flood of blank-cheque companies that raised money last year, and competition is only getting hotter. The start of the Spac boom was 2020’s story. This year is about the consummation of deals. But with more special-purpose acquisition companies floating every week, competition for the…
Read More
What do we know about the different Covid-19 vaccines for Hong Kong, and which one should you take?
Hong Kong has agreed to buy 22.5 million doses of vaccine, with three companies supplying 7.5 million shots eachOf the jabs coming from Sinovac Biotech, Pfizer-BioNTech, and AstraZeneca, only the first two have official approval for use in the city Hong Kong is set to roll-out its universal coronavirus vaccination programme next…
Read More
分享所得 相互依存 中國在全球生物科技領域的角色
過去幾個月，中國有份研發的新冠病毒疫苗在亞洲、非洲和拉丁美洲地區廣泛地進行臨床試驗，也獲得各國政府的緊急使用授權。因應這現象，有英美傳媒分析北京實施「疫苗外交」（vaccine diplomacy），是為了修補國際形象。筆者雖然同意「疫苗外交」之說，但認為其主要目的並非是為了修補形象，而是要配合北京已部署良久的生物科技產業戰略，長遠構建新一代全球生物相互依存關係。 (繼續閱讀…)
Read More
The top 10 biotech IPOs of 2020
The class of 2020 biotech IPOs will go down as one of the most buoyant in history, with the leading 10 raising a massive $3.19 billion collectively. During a year when almost every other sector suffered, life sciences had a stellar year, boosted rather than battered by the global pandemic,…
Read More
Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review
Despite the initial shock of the COVID-19 pandemic, 2020 was a standout year for biopharma. The top 600 biopharma companies added $487bn in market capitalisation, and smaller biotechs saw a record-breaking $12.8bn raised by IPO and $20bn invested by venture financers. Fortunes in the medical device industry were more divided.…
Read More
How a drug development plan can save your biotech money
The drug development industry has seen a major shift of clinical activity away from large pharmaceutical companies in favour of therapies developed by biotechs and small-to-mid-sized biopharmas. From the 53 new treatments approved in 2020 by the FDA, 39 were from smaller biotechs – up from only 29 in 2018.…
Read More
2020經濟高峰論壇｜黃克強：科技園是香港最大研發集中地
香港科技園行政總裁黃克強出席《香港01》2020 經濟高峰論壇時表示，過去兩年中美角力、社會事件及疫情影響之下，科技園發展仍然相當不錯，園內公司較4年前增長1倍至1,000家；工作人員達14,000人，當中有9,000人是研發人員，形容科技園已是香港最大的研發集中地。 (繼續閱讀…)
Read More
Johnson & Johnson’s Vaccine Offers Strong Protection but Fuels Concern About Variants
The vaccine’s efficacy rate dropped from 72 percent in the United States to just 57 percent in South Africa, where a highly contagious variant is driving most cases. A dose of Johnson & Johnson’s vaccine candidate was prepared at the Rocky Mountain Regional VA Medical Center in Aurora, Colo., last…
Read More
Affordability and efficiency is the future of healthcare
COVID has highlighted the differences in healthcare affordability across the globe, with a glimpse into what the future of medicine could look like if we don’t act. The experience of the pandemic has shown that the healthcare system can adapt quickly to changing conditions. Photo: Shutterstock Healthcare is usually a slow-moving industry, and mostly…
Read More
Embryonic Gene Editing: How Far is Too Far to Find a Treatment for Your Child?
Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the news as part of the rush to develop COVID-19 treatments and vaccines, Weldon highlights the arguments for and against embryonic gene editing from a patient/parent perspective and makes…
Read More
Hong Kong biotech could thrive in Covid crisis
Territory has the capital and companies to bolster its health technology sector but still lacks the necessary talent For all the raucous politicking that goes on in the city, Hong Kong is – perhaps surprisingly – one of the cities in the world most suited for consolidated biotech innovation. And…
Read More
The pandemic hasn’t slowed hiring at local biotech and tech companies
What does it mean to be part of the “quaranteam?” If you got hired last year at Constellation Pharmaceuticals, but no one has yet met you face-to-face, you’re on it. The Cambridge company is developing an array of drugs to treat cancer, and it hired about 75 people over the…
Read More
Biden and biotech: Science first
The November election now seems such a long time ago: It has, in fact, been less than three months, but that time has been filled with political and scientific catastrophes that will shape President Joe Biden’s term in office. The pandemic still rages on in the U.S. Whether this is…
Read More
首創三合一病毒測試劑 「本地薑」 產品歐盟認證
海康生命科技主席于常海（左）帶領團隊研發全港首創的「三合一」病毒測試技術 新冠肺炎全球大流行，世界各地衍生變種病毒，全球嚴陣以待。本港有科技公司在政府資助下，首創「三合一」病毒檢測試劑，獲歐盟認證，以新技術提高對新冠病毒、甲型或乙型季節性流感的靈敏性，有效防止發生假陽性，並能辨認病毒有否變異。帶領研發團隊的海康生命科技有限公司主席于常海對本報說，生物科技業界能為社會抗疫出一分力，其「本地薑」檢測產品是明證。 (繼續閱讀…)
Read More
Study: Biotech no riskier for investors
Despite lower sales, lack of profits and heavy R&D spending, biotech companies that went public between 1997 and 2016 reached similar market caps as non-biotech companies, according to an academic study. Before they ever make a dime, biotech startups incur steep costs to research and develop new therapies. But despite…
Read More
Spain’s BioTech Foods To Lead US$6.3M Government-Backed Cultured Meat Project
Spanish startup BioTech Foods will be leading a new government-backed project that will see ten research institutions and seven organisations come together to make meat directly from animal cells. The aim of the project is to develop healthier and more sustainable alternative proteins, including research into cultured meat that could prevent colon…
Read More
未盈利生物科技公司2020年香港IPO盘点：上市14家，平均每家募资约29亿
香港已成为全球第二大生物科技集资中心。 自港交所2018年修改《上市规则》引入18A章，允许生物科技公司来香港上市以来，截止至2020年12月31日，共有 28 家未盈利生物科技公司根据上市规则第18A章在香港交易所主板上市。 (繼續閱讀…)
Read More
Biotech’s Price Tag Is Crazy but Not Insane
Startup Sana Biotechnology could go public at a $10 billion valuation. Recent history suggests the high price tag may be worth it. PHOTO: WATCHARA PHOMICINDA/ZUMA PRESS A biotechnology startup is poised to go public with a roughly $10 billion price tag a year before it begins human clinical trials for its…
Read More
ACS Cancer Statistics Report Shows Record Drop in Cancer Mortality, But Persistent Disparities
The 2021 American Cancer Society annual Cancer Statistics report found that the overall rate of cancer mortality continuously declined from 1991 to 2018 but also highlighted racial and geographic disparities. The 2021 American Cancer Society (ACS) annual Cancer Statistics report found that while the overall rate of cancer mortality continuously declined from…
Read More
Acquisitions of Biotech Startups Increased in 2020, With No Signs of Slowing Down
2020 saw a substantial increase in the number of acquisitions of startup biotechnology companies. Many buyers are becoming increasingly interested in buying these promising companies before they go public, as this often makes the purchase more economically feasible. Acquisitions of startup biotech firms increased in 2020 in spite of the ongoing pandemic,…
Read More
China approves two GM crop varieties in bid to support biotechnology and boost food security
China last year approved three domestically designed GMO crops as safe, the first in a decade, in a fresh push towards commercial planting of GMO crops in the world’s top soybean importer and a major corn buyer. Beijing has never permitted planting of GMO soybean or corn varieties but it…
Read More
Biogen, Genentech and F-Prime power new neurodegenerative biotech to $110M unveiling
Atalanta Therapeutics has broken cover with $110 million from a series A round and partnerships with Biogen and Genentech. The biotech secured the deals and funding on the strength of evidence it can durably silence genes in the brain. Research into the genetics of neurodegenerative diseases has pointed to new, better ways…
Read More
How pharmaceutical innovation is saving the world
The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes. Nine months. In March 2020, the United States was in the early stages of the COVID-19 pandemic. We shut the entire country down and ground the economy to a halt in an…
Read More
英國六旬翁換腎失敗再患淋巴癌確診新冠肺炎後腫瘤竟離奇消失
新冠肺炎疫情於全球各國帶來數以萬計的死亡個案，科學家們日以繼夜研究，期望找到應對病毒的方法。英國有醫學雜誌近日刊出臨床病例，指1名患嚴重腎病及淋巴癌六旬男子因呼吸困難入院，不幸確診新冠肺炎。不過4個月後，男子的斷層掃描報告竟顯示體內的腫瘤離奇消失，科研人員不排除情況因新冠病毒觸發人體抗腫瘤免疫反應所致，將循相關方向研究。 (繼續閱讀…)
Read More
3 Biotech Technological Developments to Watch Out For in 2021
The biotech industry boomed in 2020 due to development of COVID-19 medicines/vaccines as well as positive developments in other therapeutic areas too. The industry is expected to grow further due to increased financial support, following promising outcomes from studies on new innovative medicines for a variety of diseases. Drug/biotech companies…
Read More
港股Biotech公司这一年
2020年是跌宕起伏的大片，我们每个人都是被推至前沿、置身其中的主角。公共卫生事件改变了很多人、很多国家、甚至很多产业。虽然公共卫生事件仍在全球肆虐，但经过医药公司、医生和各界的不懈努力，各国传来疫苗相继批准上市的好消息。作为产业发展前瞻晴雨表的资本市场更是给了我们很多启示，我们一起来看看港股生物科技公司的这一年。 (繼續閱讀…)
Read More
Coronavirus: Chinese researchers’ device may detect infection in 10 minutes
Peking University team say their patented sensing chip is as accurate as the standard PCR testing, based on initial study results. They say the technology is ready for immediate use, but some think there could be challenges for mass production. It can take hours or days to get a result…
Read More
穿透血脑屏障给大脑“送药”，纳米技术取得重要进展
一直以来，当大脑需要药物治疗时，无论是因为阿尔茨海默病、脑肿瘤，还是因为脑部遭受外伤，要把药物分子送达所需的脑组织是项艰巨的挑战。给大脑送药的一道主要障碍是所谓的“血脑屏障”。新年伊始，根据《科学》子刊Science Advances的一篇研究论文，科学家们利用纳米颗粒为解决这一药物递送难题提供了一种富有潜力的新方法。 (繼續閱讀…)
Read More
Healthcare in the era of pandemic: Why 2020 was an important year of the decade
New Delhi: Covid-19 has triggered abrupt changes across the healthcare industry. There has been an alarming concern that the industry needs to reimagine healthcare in totality. Reversing the technological gap, there has been a significant shift in consumer behaviour towards healthcare in the new normal. We have seen several positive impacts…
Read More
Breakthrough for Healthcare, Agriculture, Energy: Artificial Intelligence Reveals Recipe for Building Artificial Proteins
A ribbon model of a protein. Credit: Emw/Wikimedia CC BY-SA 3.0 Proteins are essential to cells, carrying out complex tasks and catalyzing chemical reactions. Scientists and engineers have long sought to harness this power by designing artificial proteins that can perform new tasks, like treat disease, capture carbon or harvest energy,…
Read More
FDA begins process to transfer animal biotech powers from FDA
Agriculture Secretary Sonny Perdue announced that USDA is moving forward with an Advanced Notice of Proposed Rulemaking (ANPR) to solicit public input and feedback on transitioning portions of the Food and Drug Administration’s pre-existing animal biotechnology regulatory oversight to USDA. “Our livestock producers need all the tools in the toolbox…
Read More
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled through. Let’s look back at some of the top moments in the last 12 months. After the many drug approvals, startup foundations, and venture capital highs we saw in 2019, it looked like 2020 was going…
Read More
Biotech crops good for environment
CROP biotechnology has reduced pesticide use associated with environmental impact and has been proven to be beneficial for agricultural biodiversity, according to a United Kingdom-based agricultural economist and scientists from the University of the Philippines Los Baños (UPLB) during a recent online technical forum. In a recent online technical forum…
Read More
Hong Kong Makes Run at Ousting Nasdaq for Biotech Dominance
A flurry of healthcare IPOs in Hong Kong since a rule change in 2018 has been impressive. The Hong Kong market can add a biotech string to its bow as Asia's burgeoning tech sector increasingly is attracting interest from U.S. investors. So-called "cornerstone" investors from outside Asia have accounted for…
Read More
China Tech Digest: Biotech Firms Rush To List In China, Huawei Debuts Low Price Lidar
Biopharmaceutical companies rush for IPO on Science and Technology Innovation Board Recently, numerous biopharmaceutical companies such as Nanmo Biology, Jiachuang Biology, Maiwei Biology, Dana Biology, Sailun Biology have applied for IPO on the Sci-tech Innovation Board. The companies are involved in innovative drug development, innovative drug services, original and unique…
Read More
Smart farming: The growing role of precision agriculture and biotech
Efficiency and sustainability go hand-in-hand, with an added bonus: farmers improve crop yields arming has always involved risk. Risk of pestilence, water shortages or excess, and weather events are only a few of the conditions affecting successful crop growth. Applied nutrients and crop protectors help plants thrive but can result…
Read More
Biotech companies unite to engineer a better mosquito repellent
The Aedes albopictus, which can spread Zika, seen way too close. Photo: Kevin Frayer/Getty Images Biotech companies are partnering with the U.S. military to engineer a better mosquito repellent.Why it matters: More than 1 million people die each year from mosquito-borne diseases, and existing repellents are limited in their effectiveness. Using synthetic biology to…
Read More
EU companies lag far behind US in R&D on biotech and software
Despite the success this year of a few European biotech companies in the COVID-19 disaster, overall EU corporate investment in a biotech and key computing technologies lags far behind that of their US competitors, according to a new report by the European Commission’s Joint Research Centre. Despite the success this…
Read More
Whisky industry and biotech innovators collaborate to find new sustainable solutions
An exciting new project launches this week that brings together Scotland’s most successful export industry and leading biotechnology innovators to find new sustainable solutions from whisky co-products. The Whisky Project is led by the Industrial Biotechnology Innovation Centre (IBioIC), co-funded by Zero Waste Scotland, and with additional support from the Scotch…
Read More
Biotech pigs approved for food and potential medical uses
US FDA gives green light to pigs genetically engineered to lack allergenic sugar The US Food and Drug Administration has approved the first genetically modified animal for both human food consumption and possible biomedical uses, the agency announced Dec. 14. The animals are a line of domestic pigs engineered to lack…
Read More
Biotech, pharma investments on VC radar in 2021 – PitchBook
(Reuters) - The two main areas for venture capitalist (VC) investment - technology and healthcare - have grown during the COVID-19 pandemic and investors have ample dry powder to direct money at biotech and pharma firms in 2021, research firm PitchBook said on Monday. There is mixed news heading into…
Read More
People still cautious about biotech research
Survey highlights nuanced nature of public opinion. As new biotechnologies become a reality, scientists and governments are grappling with the ethical and regulatory implications. Now, an in-depth survey from the Pew Research Center in the US has provided insight into what the average Joe is thinking, too. The survey examined…
Read More
[THE HINDU] Coronavirus | About 130 Covaxin trial volunteers may test positive, says Bharat Biotech
Possible COVID-19 infection built into Covaxin vaccine trial design; Bharat Biotech to perform interim analysis in due course. Vaccine maker Bharat Biotech’s Phase-3 clinical trial design for its candidate Covaxin expects 130 COVID-19 infections among trial participants, according to details shared by the company on the government’s clinical trial website.Thus instances such as Haryana Health…
Read More